GI
GSK icon

Glovista Investments’s GSK GSK Stock Holding History

Glovista Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-62,759
Closed -$3.4M – 100
2016
Q2 		$3.4M Sell
62,759
-46,283
-42% -$2.44M 0.61% 27
2016
Q1 		$5.53M Buy
+109,042
New +$5.43M 0.92% 21

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Glovista Investments's GSK Position: Q3 2016 in Review

Glovista Investments sold out of GSK (GSK) in Q3 2016, closing a stake of 62,759 shares — an estimated $3.4M sold.

Glovista Investments first reported a position in GSK in Q1 2016 and held it in 2 quarters. The position peaked at $5.53M in Q1 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • Glovista Investments reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
  • Glovista Investments sold 62,759 GSK shares in Q3 2016, an estimated $3.4M.
  • Glovista Investments first reported a position in GSK in Q1 2016 and held it in 2 quarters.
  • Glovista Investments's GSK position peaked at $5.53M in Q1 2016.
  • 740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Glovista Investments's 13F filing for Q3 2016, filed 14 Nov 2016.